Tech ETFs: VGT and IYW in a Duel of Cost and Diversification

Though their charts of market dominion overlap, the disparities in their fiscal burdens, breadth of holdings, and recent tempests may sway investors toward divergent shores.

Though their charts of market dominion overlap, the disparities in their fiscal burdens, breadth of holdings, and recent tempests may sway investors toward divergent shores.

Let us examine their vital statistics, though numbers often lie like diplomats at a banquet.
This triumph ended a seven-day outflow streak-a veritable financial exodus of £1.12 billion-that had left investors clutching their portfolios like a Victorian maiden clutching her pearls. A welcome respite, if you’ll pardon the pun.

VEA’s got more assets than a widow’s inheritance – $260 billion to SPDW’s $33.5. Same 0.03% fee, but VEA’s yield’s higher, if you’re into that sort of thing. Both funds twitched like corpses in a morgue when the market coughed – betas of 1.03 and 1.06. Five years back, they’d both taken bullets: SPDW down 30.23%, VEA 29.71%. Close enough to call it a tie in a knife fight.

Lo! The venerable Mr. Crypto Whale, a sage of the digital realm, unveils a logarithmic chart-a sacred scroll-foretelling a $210,000 peak in 2026. “Cycles don’t lie!” he proclaims, as if the market were a fickle lover who always keeps her promises. 🧙♂️✨

On September 30, Hood River’s portfolio acquired 1.51 million shares of Tower Semiconductor (TSEM 2.07%), a transaction that crystallized into $109.22 million of marketable intent. This 1.29% stake in their $8.47 billion constellation of American equities elevates their holdings to 152 celestial bodies-a cosmic portfolio where Tower now orbits as a bright, if peculiar, star.

On a day when the sun burned low over Hong Kong’s skyline and the tides of capital ebbed and flowed like the restless sea, Oxbow Capital Management, a fund as old as the cobblestone streets of its birthplace, filed a report with the SEC that would echo through the halls of financial folklore. In the third quarter, the fund had acquired 1.98 million shares of Wolverine World Wide, staking a claim worth $54.43 million-9.5% of its reported U.S. equity assets-like a gambler placing bets on a horse whose hooves had grown slick with doubt.

As the tale unfolds-according to that same SEC missive-Valiant Capital has now amassed a grand total of 6.48 million shares of our dear friend Core Scientific, culminating in a market value of $116.31 million as of the 30th of September. To add a sprinkle of intrigue, the fund has also secured call options tied to approximately 4.21 million shares; one can only assume they have their eyes firmly set on the future.

Transaction value based on SEC Form 4 weighted average purchase price ($23.33).